Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 218, Issue 7, Pages -
Publisher
Rockefeller University Press
Online
2021-04-23
DOI
10.1084/jem.20210554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
- (2021) Romain Lévy et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Global absence and targeting of protective immune states in severe COVID-19
- (2021) Alexis J. Combes et al. NATURE
- Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
- (2021) Timothy J. Break et al. SCIENCE
- Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
- (2021) Nicolas de Prost et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway
- (2021) Isabelle Meyts et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
- (2021) Rutger Koning et al. INTENSIVE CARE MEDICINE
- Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
- (2021) Andri Lemarquis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
- (2021) Jesús Troya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
- (2021) Paul Bastard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor
- (2020) G. Beccuti et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Susceptibility to severe COVID-19
- (2020) David B. Beck et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
- (2020) Christopher J.A. Duncan et al. TRENDS IN GENETICS
- A novel case of homozygous IFNAR1 deficiency with haemophagocytic lymphohistiocytosis
- (2020) Florian Gothe et al. CLINICAL INFECTIOUS DISEASES
- Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency
- (2020) Paul Bastard et al. JOURNAL OF CLINICAL INVESTIGATION
- A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
- (2020) Lorena Sanchez-Felipe et al. NATURE
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
- (2020) Ventura A. Simonovich et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines
- (2019) Nicholas Hernandez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance
- (2019) Elise M. N. Ferré et al. Science Translational Medicine
- New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response
- (2019) Huie Jing et al. CURRENT OPINION IN PEDIATRICS
- The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)
- (2018) Can-Jie Guo et al. AUTOIMMUNITY REVIEWS
- Autoimmune Polyendocrine Syndromes
- (2018) Eystein S. Husebye et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
- (2018) Gregory M. Constantine et al. IMMUNOLOGICAL REVIEWS
- Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1
- (2017) Elizaveta M Orlova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
- (2016) Steffen Meyer et al. CELL
- A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1
- (2016) Øyvind Bruserud et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Central tolerance to self revealed by the autoimmune regulator
- (2015) Alice Y. Chan et al. Annals of the New York Academy of Sciences
- Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases
- (2015) Bergithe E. Oftedal et al. IMMUNITY
- Human IFNAR2 deficiency: Lessons for antiviral immunity
- (2015) Christopher J. A. Duncan et al. Science Translational Medicine
- Interferons and viruses: an evolutionary arms race of molecular interactions
- (2015) Hans-Heinrich Hoffmann et al. TRENDS IN IMMUNOLOGY
- A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1
- (2014) Lars Breivik et al. CLINICAL IMMUNOLOGY
- Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
- (2013) Gillian I Rice et al. LANCET NEUROLOGY
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
- (2010) Anne Puel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
- (2010) Kai Kisand et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started